Supernus Pharmaceuticals ... (SUPN)
NASDAQ: SUPN
· Real-Time Price · USD
43.16
0.99 (2.35%)
At close: Aug 15, 2025, 12:41 PM
Supernus Pharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | 19.62 | -38.67 | 32.71 | 11.17 | 18.32 | 3.7K | 336.49 | -23.56 | -492.89 | 29.06 | 18.93 | 260.26 | 49.11 | 18.72 | 158.92 | 16.45 | 17.20 | 60.84 |
PEG Ratio | -0.07 | 0.22 | -0.55 | 0.12 | 0.00 | -41.47 | -3.13 | -0.01 | 4.70 | -0.85 | 0.01 | -3.32 | -0.75 | 0.02 | -1.81 | -1.85 | 0.06 | -0.75 |
PS Ratio | 10.67 | 12.21 | 11.52 | 9.79 | 8.67 | 12.79 | 9.62 | 9.78 | 12.09 | 12.81 | 11.53 | 10.27 | 9.09 | 12.58 | 9.76 | 9.55 | 11.55 | 10.58 |
PB Ratio | 1.66 | 1.78 | 1.94 | 1.71 | 1.52 | 1.98 | 1.72 | 1.65 | 1.78 | 2.16 | 2.18 | 2.14 | 1.84 | 2.32 | 1.90 | 1.75 | 2.08 | 1.84 |
P/FCF Ratio | 30.40 | 60.44 | 45.38 | 32.25 | 41.05 | 48.15 | 35.15 | 42.14 | -86.08 | 40.33 | 67.90 | 132.96 | 21.55 | 555.85 | 31.86 | -307.9 | 35.27 | 39.94 |
P/OCF Ratio | 30.17 | 59.79 | 45.17 | 32.13 | 40.97 | 47.84 | 35.18 | 41.97 | -86.81 | 40.11 | 70.02 | 131.55 | 21.73 | 445.90 | 31.83 | -345.14 | 35.27 | 38.28 |
OCF/S Ratio | 0.35 | 0.20 | 0.25 | 0.30 | 0.21 | 0.27 | 0.27 | 0.23 | -0.14 | 0.32 | 0.16 | 0.08 | 0.42 | 0.03 | 0.31 | -0.03 | 0.33 | 0.28 |
Debt / Equity Ratio | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | 0.57 | 0.49 | 0.51 | 0.53 | 0.54 | 0.52 | 0.51 | 0.52 | 0.52 |
Quick Ratio | 2.43 | 2.26 | 2.16 | 1.98 | 1.69 | 1.49 | 1.43 | 1.27 | 1.32 | 1.08 | 0.93 | 0.80 | 0.73 | 1.69 | 1.63 | 2.59 | 2.05 | 2.22 |
Current Ratio | 2.58 | 2.44 | 2.35 | 2.20 | 1.91 | 1.73 | 1.70 | 1.56 | 1.68 | 1.21 | 1.07 | 0.91 | 0.85 | 2.00 | 1.91 | 2.85 | 2.26 | 2.43 |
Asset Turnover | 0.12 | 0.11 | 0.13 | 0.13 | 0.13 | 0.11 | 0.12 | 0.12 | 0.10 | 0.09 | 0.10 | 0.10 | 0.10 | 0.09 | 0.09 | 0.10 | 0.09 | 0.09 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -19.33 | 5.90 | 21.54 | 1.02 | 6.27 | 8.92 | 1.03 | 5.50 | 6.24 | 2.17 |
Return on Equity | 0.02 | -0.01 | 0.01 | 0.04 | 0.02 | n/a | n/a | -0.02 | n/a | 0.02 | 0.03 | n/a | 0.01 | 0.03 | n/a | 0.03 | 0.03 | 0.01 |
Return on Assets | 0.02 | -0.01 | 0.01 | 0.03 | 0.02 | n/a | n/a | -0.01 | n/a | 0.01 | 0.01 | n/a | n/a | 0.02 | n/a | 0.01 | 0.02 | n/a |
Return on Invested Capital | 0.01 | -0.02 | 0.01 | 0.03 | 0.01 | n/a | 0.02 | -0.01 | n/a | 0.01 | 0.02 | -0.01 | 0.01 | 0.02 | 0.01 | 0.02 | 0.02 | 0.01 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.77 | 0.89 | 0.85 | 0.79 | 0.77 | 0.74 | 0.75 | 0.87 | 0.84 | 0.85 | 0.86 | 0.85 | 0.88 | 0.88 | 0.89 | 0.88 | 0.82 | 0.89 |
Net Profit Margin | 0.14 | -0.08 | 0.09 | 0.22 | 0.12 | 0.00 | 0.01 | -0.1 | -0.01 | 0.11 | 0.15 | 0.01 | 0.05 | 0.17 | 0.02 | 0.15 | 0.17 | 0.04 |
Pretax Profit Margin | 0.10 | -0.04 | 0.15 | 0.26 | 0.16 | 0.00 | 0.01 | 0.06 | -0.13 | 0.06 | 0.21 | -0.00 | 0.07 | 0.10 | 0.01 | 0.20 | 0.22 | 0.08 |
Operating Profit Margin | 0.07 | -0.07 | 0.12 | 0.23 | 0.11 | -0.03 | 0.12 | 0.05 | -0.13 | 0.06 | 0.21 | 0.01 | 0.07 | 0.11 | 0.04 | 0.22 | 0.24 | 0.10 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | 0.23 | 0.12 | 0.26 | 0.37 | 0.23 | 0.11 | 0.25 | 0.19 | 0.03 | 0.16 | 0.35 | 0.13 | 0.20 | 0.16 | 0.13 | 0.28 | 0.31 | 0.18 |